New England Compounding Pharmacy in Framingham, Mass., distributed steroid injections tainted with fungus that caused an outbreak spanning 20 states.
The settlement will be directed into a compensation fund that will be distributed to the pharmacy’s creditors and victims of the tainted steroid injections, according to the report.
NECC has so far received 322 lawsuits and 3,300 claims of injury in relation to the compounding outbreak, according to the report.
In December 2012, NECC filed for bankruptcy protection due to the number of lawsuits received.
More Articles on Settlements:
Baptist Health Settles False Claims Allegations For $2.5M
Rhode Island HIE Settles With ACLU Over Patient Privacy
5 Things to Know About the Sanford Health Spinal Implant Settlement Agreement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.